| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| ChiCTR-INR-16009867 |
PhaseⅠclinical research of personalized neo-antigen peptides for the treatment of lung cancer Tianjin Beichen Hospital |
Non-small cell lung cancer |
Therapy Study |
Premarket |
2018-11-22 | 1860 | Patient list |
| ChiCTR-IIR-17010557 |
Phase I Clinical Trial of Autologous Mutation Peptides for the Treatment of Lung Cancer Tianjin Beichen Hospital |
|
Therapy Study |
Premarket |
2018-11-22 | 960 | Patient list |